Skip to content
← Back to this collection

PUBLICATIONS · 22368272

Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2012 Apr 12
First author
Chen IM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Chen IM
      type
      Author
    2. name
      Harvey RC
      type
      Author
    3. name
      Mullighan CG
      type
      Author
    4. name
      Gastier-Foster J
      type
      Author
    5. name
      Wharton W
      type
      Author
    6. name
      Kang H
      type
      Author
    7. name
      Borowitz MJ
      type
      Author
    8. name
      Camitta BM
      type
      Author
    9. name
      Carroll AJ
      type
      Author
    10. name
      Devidas M
      type
      Author
    11. name
      Pullen DJ
      type
      Author
    12. name
      Payne-Turner D
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Chen IM
      type
      Author
    2. name
      Harvey RC
      type
      Author
    3. name
      Mullighan CG
      type
      Author
    4. name
      Gastier-Foster J
      type
      Author
    5. name
      Wharton W
      type
      Author
    6. name
      Kang H
      type
      Author
    7. name
      Borowitz MJ
      type
      Author
    8. name
      Camitta BM
      type
      Author
    9. name
      Carroll AJ
      type
      Author
    10. name
      Devidas M
      type
      Author
    11. name
      Pullen DJ
      type
      Author
    12. name
      Payne-Turner D
      type
      Author
    bibliography ids
    1. nci-bib-46212e45e0c007a062c3b830
    book metadata
    content sha256
    81bc1c67aed39ea113f1b7eddd75ab3e11e5f97aa86142d5225f4ae98b3fba58
    document type
    citation
    dois
    1. 10.1182/blood-2011-11-394221
    electronic publication date
    display
    2012 Feb 24
    precision
    day
    year
    2012
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:22368272
    immutable id
    pubmed:22368272@81bc1c67aed39ea113f1b7eddd75ab3e11e5f97aa86142d5225f4ae98b3fba58
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    15
    name
    Blood
    nlm unique id
    7603509
    pages
    3512-22
    volume
    119
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      22368272
      provenance
      batch id
      b6284687e167e7da9556
      provider
      NCBI PubMed ESummary
      record sha256
      fc0d8d1e98e3d62fcc7511c2ffffe1ee37a971e675a7b8122bb4346d725f1c30
      response sha256
      64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
      retrieved at
      2026-09-09T23:46:45.216259+00:00
      publication date
      display
      2012 Apr 12
      precision
      day
      year
      2012
      publication types
      1. Evaluation Study
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/22368272/
      title
      Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.

      Preserved source evidence · Independent clinical review pending · Not medical advice